An inverse association between ovarian cysts and breast cancer in the breast cancer family registry
暂无分享,去创建一个
A. Whittemore | G. Giles | J. Hopper | E. John | A. Ziogas | R. Milne | I. Andrulis | J. Knight | G. Dite | Ellen J. Q. Shi | R. Balbuena
[1] D. Guzick. Polycystic ovary syndrome. , 2007, Obstetrics and gynecology.
[2] Ricardo Azziz,et al. 0021-972X/04/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 89(6):2745–2749 Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/jc.2003-032046 The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected , 2022 .
[3] Norman Boyd,et al. The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer , 2004, Breast Cancer Research.
[4] I. Andrulis,et al. Genetic Variants of GPX1 and SOD2 and Breast Cancer Risk at the Ontario Site of the Breast Cancer Family Registry , 2004, Cancer Epidemiology Biomarkers & Prevention.
[5] A. Belgorosky,et al. Hypothalamic-pituitary-ovarian axis during infancy, early and late prepuberty in an aromatase-deficient girl who is a compound heterocygote for two new point mutations of the CYP19 gene. , 2003, The Journal of clinical endocrinology and metabolism.
[6] J. Daling,et al. Oral Contraceptives, Tubal Sterilization, and Functional Ovarian Cyst Risk , 2003, Obstetrics and gynecology.
[7] I. Yang,et al. Management of Ovarian Cysts in Women Undergoing Restorative Proctocolectomy for Ulcerative Colitis , 2003, The American surgeon.
[8] John L Hopper,et al. Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations. , 2003, Journal of the National Cancer Institute.
[9] P. Viganò,et al. Endometriosis: novel etiopathogenetic concepts and clinical perspectives. , 2002, Fertility and sterility.
[10] R. Homburg. What is polycystic ovarian syndrome? A proposal for a consensus on the definition and diagnosis of polycystic ovarian syndrome. , 2002, Human reproduction.
[11] C. Bondy,et al. Androgens and mammary growth and neoplasia. , 2002, Fertility and sterility.
[12] R. Dickson,et al. Roles of androgens in the development, growth, and carcinogenesis of the mammary gland , 2002, The Journal of Steroid Biochemistry and Molecular Biology.
[13] N. Boyd,et al. Characteristics associated with participation at various stages at the Ontario site of the cooperative family registry for breast cancer studies. , 2002, Annals of epidemiology.
[14] L. Plouffe,et al. The Effect of Selective Estrogen Receptor Modulators on Parameters of the Hypothalamic‐Pituitary‐Gonadal Axis , 2001, Annals of the New York Academy of Sciences.
[15] I. Vauhkonen,et al. Metabolic and steroidogenic alterations related to increased frequency of polycystic ovaries in women with a history of gestational diabetes. , 2001, The Journal of clinical endocrinology and metabolism.
[16] H. Hollema,et al. TAMOXIFEN TREATMENT AND GYNECOLOGIC SIDE EFFECTS: A REVIEW , 2001, Obstetrics and gynecology.
[17] P. Vercellini,et al. Ovarian and endometrial function during hormonal contraception. , 2001, Human reproduction.
[18] C. Rao. Does full-term pregnancy at a young age protect women against breast cancer through hCG? , 2000, Obstetrics and gynecology.
[19] The prevalence of polycystic ovaries in women with a history of gestational diabetes , 2000, Clinical endocrinology.
[20] R. Hirasing,et al. Polycystic ovaries in adolescents and the relationship with menstrual cycle patterns, luteinizing hormone, androgens, and insulin. , 2000, Fertility and sterility.
[21] R. Hoover,et al. Tubal ligation and risk of breast cancer , 2000, British Journal of Cancer.
[22] J. Russo,et al. Hormonal approach to breast cancer prevention , 2000, Journal of cellular biochemistry. Supplement.
[23] G. Giles,et al. Design and analysis issues in a population-based, case-control-family study of the genetic epidemiology of breast cancer and the Co-operative Family Registry for Breast Cancer Studies (CFRBCS). , 1999, Journal of the National Cancer Institute. Monographs.
[24] Polycystic ovaries and associated clinical and biochemical features in young women , 1999, Clinical endocrinology.
[25] M. Cotterchio,et al. The risk of breast cancer following reproductive surgery. , 1999, European journal of cancer.
[26] U. Ekblad,et al. Polycystic Ovaries in Women With Gestational Diabetes , 1998, Obstetrics and gynecology.
[27] C. Berne,et al. High prevalence of polycystic ovaries and associated clinical, endocrine, and metabolic features in women with previous gestational diabetes mellitus. , 1998, The Journal of clinical endocrinology and metabolism.
[28] T. Sellers,et al. Association of Stein‐Leventhal syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa , 1997, Cancer.
[29] E. Negri,et al. Association of Stein‐Leventhal Syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa , 1997, Cancer.
[30] Y. Ito,et al. A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom). , 1994, The Journal of clinical endocrinology and metabolism.
[31] W. Thompson,et al. Polycystic ovaries and the risk of breast cancer. , 1991, American journal of epidemiology.
[32] C R Weinberg,et al. The design and analysis of case-control studies with biased sampling. , 1990, Biometrics.
[33] P. Wingo,et al. Hysterectomy, tubal sterilization, and the risk of breast cancer. , 1988, American journal of epidemiology.
[34] M. Rosner,et al. Growth factors modify the epidermal growth factor receptor through multiple pathways , 1987, Journal of cellular biochemistry.
[35] J. Annegers,et al. Chronic Anovulation Syndrome and Associated Neoplasia , 1983, Obstetrics and gynecology.